{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:38:00Z","timestamp":1791610680602,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006424","name":"F\u00e9d\u00e9ration pour la Recherche sur le Cerveau","doi-asserted-by":"publisher","award":["ANR-10-IAIHU-06"],"award-info":[{"award-number":["ANR-10-IAIHU-06"]}],"id":[{"id":"10.13039\/501100006424","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018231","name":"Aligning Science Across Parkinson's","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008211","name":"Association France Parkinson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Foundation for Medical Research","doi-asserted-by":"publisher","award":["MND202004011718"],"award-info":[{"award-number":["MND202004011718"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Neurobiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.conb.2025.103141","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:29:12Z","timestamp":1763634552000},"page":"103141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The genetics of autosomal recessive early-onset Parkinson's disease"],"prefix":"10.1016","volume":"95","author":[{"given":"Guillaume","family":"Cogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Lesage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0941-3990","authenticated-orcid":false,"given":"Alexis","family":"Brice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.conb.2025.103141_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mds.870020201","article-title":"Young onset Parkinson's disease","volume":"2","author":"Quinn","year":"1987","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.conb.2025.103141_bib2","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1212\/WNL.43.6.1150","article-title":"Environmental antecedents of young-onset Parkinson's disease","volume":"43","author":"Butterfield","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2025.103141_bib3","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1093\/brain\/awae142","article-title":"Parkinson's disease variant detection and disclosure: PD GENEration, a North American study","volume":"147","author":"Cook","year":"2024","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.conb.2025.103141_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41531-024-00778-z","article-title":"Parkinson's families project: a UK-wide study of early onset and familial Parkinson's disease","volume":"10","author":"Towns","year":"2024","journal-title":"NPJ Park Dis"},{"key":"10.1016\/j.conb.2025.103141_bib5","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neurol.2018.08.004","article-title":"The genetic landscape of Parkinson's disease","volume":"174","author":"Lunati","year":"2018","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.conb.2025.103141_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson's disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.conb.2025.103141_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/mds.29314","article-title":"Classification of GBA1 variants in Parkinson's disease: the GBA1-PD browser","volume":"38","author":"Parlar","year":"2023","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.conb.2025.103141_bib8","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/brain\/awae073","article-title":"Genetic analysis and natural history of Parkinson's disease due to the LRRK2 G2019S variant","volume":"147","author":"Kmiecik","year":"2024","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.conb.2025.103141_bib9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/genes13030471","article-title":"Monogenic Parkinson's disease: Genotype, phenotype, pathophysiology, and genetic testing","volume":"13","author":"Jia","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.conb.2025.103141_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10571-020-00849-8","article-title":"The role of VPS35 in the pathobiology of Parkinson's disease","volume":"41","author":"Sassone","year":"2021","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.conb.2025.103141_bib11","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s41588-024-01787-7","article-title":"Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson's disease","volume":"56","author":"Hop","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.conb.2025.103141_bib12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41531-024-00752-9","article-title":"Loss-of-function variants in ITSN1 confer high risk of Parkinson's disease","volume":"10","author":"Skuladottir","year":"2024","journal-title":"NPJ Park Dis"},{"key":"10.1016\/j.conb.2025.103141_bib13","doi-asserted-by":"crossref","first-page":"115355","DOI":"10.1016\/j.celrep.2025.115355","article-title":"Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson's disease","author":"Spargo","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.conb.2025.103141_bib14","doi-asserted-by":"crossref","first-page":"147749","DOI":"10.1016\/j.gene.2023.147749","article-title":"GTP cyclohydroxylase1 (GCH1): Role in neurodegenerative diseases","volume":"888","author":"Gupta","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.conb.2025.103141_bib15","first-page":"1","article-title":"A practical approach to early-onset parkinsonism","volume":"12","author":"Riboldi","year":"2022","journal-title":"J Park Dis"},{"key":"10.1016\/j.conb.2025.103141_bib16","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/WNL.38.9.1402","article-title":"A comparison of clinical and pathological features of young- and old-onset Parkinson's disease","volume":"38","author":"Gibb","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2025.103141_bib17","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","article-title":"Association between early-onset Parkinson's disease and mutations in the parkin gene","volume":"342","author":"L\u00fccking","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.conb.2025.103141_sref18","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1093\/brain\/awae188","article-title":"Relevance of genetic testing in the gene-targeted trial era: the rostock Parkinson's disease study","volume":"147","author":"Westenberger","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.conb.2025.103141_bib19","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/brain\/awaa167","article-title":"The role of genetics in Parkinson's disease: a large cohort study in Chinese mainland population","volume":"143","author":"Zhao","year":"2020","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.conb.2025.103141_bib20","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1111\/ene.15509","article-title":"The mutation spectrum of parkinson-disease-related genes in early-onset Parkinson's disease in ethnic Chinese","volume":"29","author":"Chen","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.conb.2025.103141_bib21","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/mds.29617","article-title":"Harmonizing genetic testing for Parkinson's disease: results of the PARKNET multicentric study","volume":"38","author":"Di Fonzo","year":"2023","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.conb.2025.103141_bib22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ana.25787","article-title":"Characterization of recessive parkinson disease in a large multicenter study","volume":"88","author":"Lesage","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.conb.2025.103141_sref23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41531-024-00677-3","article-title":"Genotype-phenotype correlation in PRKN-associated Parkinson's disease","volume":"10","author":"Menon","year":"2024","journal-title":"NPJ Park Dis"},{"key":"10.1016\/j.conb.2025.103141_bib24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mds.20343","article-title":"Novel parkin mutations detected in patients with early-onset Parkinson's disease","volume":"20","author":"Bertoli-Avella","year":"2005","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"Pt 6","key":"10.1016\/j.conb.2025.103141_bib25","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/brain\/awg142","article-title":"Parkin disease: a phenotypic study of a large case series","volume":"126","author":"Khan","year":"2003","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.conb.2025.103141_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neurobiolaging.2021.12.014","article-title":"Genotype-phenotype correlation of Parkinson's disease with PRKN variants","volume":"114","author":"Yoshino","year":"2022","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.conb.2025.103141_bib27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.25364","article-title":"Levodopa-induced dyskinesia in Parkinson disease: current and evolving concepts","volume":"84","author":"Espay","year":"2018","journal-title":"Ann Neurol"},{"issue":"Pt 6","key":"10.1016\/j.conb.2025.103141_bib28","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/brain\/123.6.1112","article-title":"Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?","volume":"123","author":"Tassin","year":"2000","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.conb.2025.103141_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mds.27882","article-title":"Motor complications in Parkinson's disease: 13-year follow-up of the CamPaIGN cohort","volume":"35","author":"Kim","year":"2020","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.conb.2025.103141_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/hmg\/ddaa273","article-title":"Assessing the relationship between monoallelic PRKN mutations and Parkinson's risk","volume":"30","author":"Lubbe","year":"2021","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2025.103141_bib31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/brain\/aww261","article-title":"Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism","volume":"140","author":"Puschmann","year":"2017","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.conb.2025.103141_bib32","doi-asserted-by":"crossref","first-page":"168.e1","DOI":"10.1016\/j.neurobiolaging.2020.03.003","article-title":"Comprehensive assessment of PINK1 variants in Parkinson's disease","volume":"91","author":"Krohn","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.conb.2025.103141_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mds.28299","article-title":"Analysis of heterozygous PRKN variants and copy-number variations in Parkinson's disease","volume":"36","author":"Yu","year":"2021","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.conb.2025.103141_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/mds.30151","article-title":"Exploration of neurodegenerative diseases using long-read sequencing and optical genome mapping technologies","author":"Cogan","year":"2025","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.conb.2025.103141_sref35","article-title":"The utility of long-read sequencing in diagnosing early onset parkinson's disease","author":"Daida","year":"2024","journal-title":"Ann Neurol"},{"key":"10.1016\/j.conb.2025.103141_bib36","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/mds.29610","article-title":"Long-read sequencing resolves a complex structural variant in PRKN Parkinson's disease","volume":"38","author":"Daida","year":"2023","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.conb.2025.103141_bib37","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/mds.29914","article-title":"Long-read sequencing unravels the complexity of structural variants in PRKN in two individuals with early-onset parkinson's disease","volume":"39","author":"Cogan","year":"2024","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.conb.2025.103141_bib38","doi-asserted-by":"crossref","first-page":"e7358","DOI":"10.1002\/ccr3.7358","article-title":"Fahr's disease presenting as Parkinson's disease along with dysphagia and dysarthria: a case report","volume":"11","author":"Sapkota","year":"2023","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.conb.2025.103141_bib39","first-page":"3443","article-title":"Early neurological deterioration in Wilson's disease: a systematic literature review and meta-analysis","volume":"44","author":"Antos","year":"2023","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"10.1016\/j.conb.2025.103141_bib40","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1038\/s41467-023-37815-z","article-title":"Parkinson's disease-associated ATP13A2\/PARK9 functions as a lysosomal H+,K+-ATPase","volume":"14","author":"Fujii","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.conb.2025.103141_bib41","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1523\/JNEUROSCI.6513-10.2011","article-title":"Enhanced phosphatase activity attenuates \u03b1-synucleinopathy in a mouse model","volume":"31","author":"Lee","year":"2011","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"10.1016\/j.conb.2025.103141_bib42","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1021\/bi902160t","article-title":"Molecular determinants for PP2A substrate specificity: charged residues mediate dephosphorylation of tyrosine hydroxylase by the PP2A\/B\u2019 regulatory subunit","volume":"49","author":"Saraf","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.conb.2025.103141_bib43","doi-asserted-by":"crossref","first-page":"105426","DOI":"10.1016\/j.nbd.2021.105426","article-title":"Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation","volume":"157","author":"Drouyer","year":"2021","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.conb.2025.103141_bib44","doi-asserted-by":"crossref","first-page":"25490","DOI":"10.1074\/jbc.274.36.25490","article-title":"Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies","volume":"274","author":"Sontag","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.conb.2025.103141_sref45","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/brain\/awac326","article-title":"PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability","volume":"146","author":"Fevga","year":"2023","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.conb.2025.103141_bib46","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/mds.29411","article-title":"Cross-ethnic variant screening and burden analysis of PTPA in Parkinson's disease","volume":"38","author":"Li","year":"2023","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.conb.2025.103141_bib47","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1093\/brain\/awad244","article-title":"PTPA variants are rare in early-onset and familial Parkinson's disease","volume":"146","author":"Dulski","year":"2023","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.conb.2025.103141_bib48","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1093\/brain\/awad247","article-title":"PTPA variants and the risk for Parkinson's disease in diverse ancestry populations","volume":"146","author":"Ostro\u017eovi\u010dov\u00e1","year":"2023","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.conb.2025.103141_sref49","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1038\/s41467-022-31168-9","article-title":"Deficiency in endocannabinoid synthase DAGLB contributes to early onset Parkinsonism and murine nigral dopaminergic neuron dysfunction","volume":"13","author":"Liu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.conb.2025.103141_bib50","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/mds.29533","article-title":"Identification of a DAGLB mutation in a non-Chinese patient with Parkinson's disease","volume":"38","author":"Tesson","year":"2023","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"10.1016\/j.conb.2025.103141_bib51","article-title":"Identification of DAGLB variants in Japanese early-onset Parkinson's disease","author":"Luo","year":"2025","journal-title":"J Neural Transm Vienna Austria 1996"},{"key":"10.1016\/j.conb.2025.103141_bib52","article-title":"PSMF1 variants cause a phenotypic spectrum from early-onset Parkinson's disease to perinatal lethality by disrupting mitochondrial pathways","author":"Magrinelli","year":"2024","journal-title":"MedRxiv Prepr Serv Health Sci"},{"key":"10.1016\/j.conb.2025.103141_bib53","doi-asserted-by":"crossref","first-page":"22325","DOI":"10.1074\/jbc.M709900200","article-title":"Structure of a conserved dimerization domain within the F-box protein Fbxo7 and the PI31 proteasome inhibitor","volume":"283","author":"Kirk","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.conb.2025.103141_bib54","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.bbrc.2015.06.086","article-title":"VCP and PSMF1: antagonistic regulators of proteasome activity","volume":"463","author":"Clemen","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.conb.2025.103141_bib55","article-title":"Mutations in EPG5 are associated with a wide spectrum of neurodevelopmental and neurodegenerative disorders","author":"Dafsari","year":"2024","journal-title":"medRxiv"},{"issue":"Pt 3","key":"10.1016\/j.conb.2025.103141_bib56","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/brain\/awv393","article-title":"EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy","volume":"139","author":"Byrne","year":"2016","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.conb.2025.103141_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/ana.27242","article-title":"Biallelic variants in EPG5 gene are associated with Parkinson's disease","author":"Sun","year":"2025","journal-title":"Ann Neurol"},{"key":"10.1016\/j.conb.2025.103141_bib58","doi-asserted-by":"crossref","first-page":"101749","DOI":"10.1016\/j.xcrm.2024.101749","article-title":"A candidate loss-of-function variant in SGIP1 causes synaptic dysfunction and recessive parkinsonism","volume":"5","author":"Decet","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.conb.2025.103141_bib59","doi-asserted-by":"crossref","first-page":"26481","DOI":"10.1074\/jbc.M703815200","article-title":"SGIP1alpha is an endocytic protein that directly interacts with phospholipids and Eps15","volume":"282","author":"Uezu","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.conb.2025.103141_bib60","first-page":"557","article-title":"\u00ab safety, pharmacokinetics, and pharmacodynamics of oral venglustat in patients with Parkinson's disease and a GBA mutation: results from part 1 of the randomized, double-blinded, placebo-controlled MOVES-PD trial","volume":"12","author":"Peterschmitt","year":"2022","journal-title":"J Park Dis"},{"key":"10.1016\/j.conb.2025.103141_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108822","article-title":"New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin","volume":"202","author":"Senkevich","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.conb.2025.103141_bib62","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2019.04.029","article-title":"Therapeutic approaches to enhance PINK1\/Parkin mediated mitophagy for the treatment of Parkinson's disease","volume":"705","author":"Miller","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.conb.2025.103141_bib63","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrm2731","article-title":"Breaking the chains: structure and function of the deubiquitinases","volume":"10","author":"Komander","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.conb.2025.103141_bib64","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/j.bmcl.2018.05.013","article-title":"Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy","volume":"28","author":"Kluge","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.conb.2025.103141_bib65","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1038\/s41467-023-42876-1","article-title":"Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson's disease mouse model","volume":"14","author":"Fang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.conb.2025.103141_bib66","article-title":"Examining the effects of MTX325 on mitochondrial quality control and the prevention of Parkinson's disease progression | Parkinson's disease","year":"2025","journal-title":"Consult\u00e9 le"},{"key":"10.1016\/j.conb.2025.103141_bib67","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1038\/s41467-024-51889-3","article-title":"Activation of parkin by a molecular glue","volume":"15","author":"Sauv\u00e9","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.conb.2025.103141_bib68","first-page":"1","article-title":"Activation of endogenous PRKN by structural derepression is linked to increased turnover of the E3 ubiquitin ligase","author":"Fiesel","year":"2025","journal-title":"Autophagy"}],"container-title":["Current Opinion in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438825001722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438825001722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:31:29Z","timestamp":1780914689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959438825001722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":68,"alternative-id":["S0959438825001722"],"URL":"https:\/\/doi.org\/10.1016\/j.conb.2025.103141","relation":{},"ISSN":["0959-4388"],"issn-type":[{"value":"0959-4388","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The genetics of autosomal recessive early-onset Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conb.2025.103141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103141"}}